validation of psma-pet to the most used nomograms for pelvic lymph-node metastases prediction
Published 2 years ago • 333 plays • Length 4:11Download video MP4
Download video MP3
Similar videos
-
11:58
optimal treatment of clinically node-positive prostate cancer in the psma pet/ct era
-
13:24
clinical case presentation - "clinical lymph node metastatic prostate cancer (cn1)"
-
2:18
skipping extended pelvic lymph node dissection with negative psma pet in prostate cancer
-
46:41
pelvic lymph node dissection in prostate cancer
-
6:53
does every metastatic patient need immunotherapy in a first-line setting?
-
14:09
how psma revolutionizes staging for #prostatecancer | #markscholzmd | #pcri
-
11:01
lutetium-177: psma guided treatment | #prostatecancer | #markscholzmd | #pcri
-
35:05
psma and beyond psma for prostate cancer
-
17:58
how to integrate psma pet findings into treatment algorithms
-
5:56
understanding psma/pet, axumin, mri, ultrasound | ask a prostate expert, mark scholz, md
-
16:28
appropriate use of psma pet in clinical practice
-
4:39
psma/pet scans: fda approved | ask a prostate expert, mark scholz, md
-
9:37
psma pet imaging: a primer for the urologist or oncologist
-
9:41
can pirads determine treatment?, detecting pelvic lymph nodes
-
0:54
predicting 177lu-psma-617 in men with prostate cancer with nomograms
-
4:04
case report: detecting false-positive pet psma in the evaluation of prostate cancer
-
6:36
validation of fapi pet biodistribution
-
1:26
dr. choyke on differences between pet scans in prostate cancer
-
10:55
psma pet/ct imaging | appropriate use criteria | snmmi
-
1:09:19
current and emerging applications of psma pet
-
14:47
intraoperative psma pet for the detection of lymph node metastases
-
49:38
psma pet, mri, and mpmri imaging for prostate cancer, explained by johan stranne md